Recombinant Protein Market Forecast, Trend Analysis & Competition Tracking: Global Market insights 2017 to 2022

Published on : Aug-2017 | List of Tables : 281 | List of Figures : 105 | No. of Pages : 170 | Report Code : FACT186MR | Format :

Proteins resulting from expression of recombinant DNA (rDNA), within living cells, are known as recombinant proteins. rDNAs are DNA molecules that are formed by laboratory procedures of genetic recombination, to bring genetic material together from multiple sources. DNA sequences used for constructing recombinant DNA molecules originate from any species. If the DNA sequences do not occur in nature, they can be created through chemical synthesis of DNA, further incorporating them into recombinant molecules.

After cell engineering and genetic engineering technology, recombinant protein, which is constructed from the creature body, is now at the forefront of biotechnology production. Recombinant protein technology has become the standard, with current shifts in focus from bulk production method to post-production techniques, promising enhanced stability and delivery. Recombinant protein is highly effective, and plays an indispensable role in treatment of certain diseases, such as hemophilia (excluding blood coagulation factor that has an extremely limited source). Most of the recombinant protein drugs used are derived from human proteins, or, mutants of human proteins, for compensating functional proteins in vivo defects, or, to increase protein function in a body. This renders recombinant proteins with a significantly higher safety than small molecules, leading towards a higher approval rate.

Clinical trial period for recombinant protein is shorter as compared to small molecule drugs. This further helps in enhancing the patient protection, providing pharmaceutical companies with longer exclusive sales time. These factors have fuelled the development as well as demand for recombinant protein. Recombinant proteins are targeted at major diseases including endocrine diseases, cardiovascular diseases, cancer, and viral diseases. Moreover, the global market for recombinant proteins has larger extension space. Few approval drugs are available in the recombinant protein market, with no substitute products in therapeutic areas. However, owing to higher financial barriers, and technical barriers, recombinant proteins are subject to high costs. Replicating recombinant proteins is a more difficult task than that of small molecule chemicals. Fact.MR’s report projects the global market for recombinant protein to expand at an average CAGR during the forecast period (2017 to 2022). The market is estimated to account for nearly US$ 460 Mn revenues by 2022-end.

Market Taxonomy

Product Type

End User

Application

Immune Checkpoint Regulators

Biopharmaceutical Companies

Drug Discovery & Development

Chemokines

Contract Research Organizations (CROs)

Basic Research

Growth Factors

Academic & Research Institutes

Toxicity Screening

Cytokines

Forensic Science Laboratories

Biopharmaceutical Production

Colony Stimulating Factors

Food & Beverage Companies

Drug Screening

Hormones

Diagnostic Centers

Tissue Engineering

Enzymes & Inhibitors

Others

Forensic Testing

Other

   

(Additional information, including cross-sectional data and country-wise analysis & forecast is available in the report)

North America to Remain Dominant in the Market

North America will continue to retain its dominance in the global recombinant protein market, with sales projected to reach nearly US$ 150 Mn by 2022-end. Europe is estimated to be the second most lucrative market for recombinant protein throughout the forecast period. The market in Middle East & Africa (MEA) is anticipated to witness a sluggish expansion through 2022.

Recombinant proteins factoring molecular growth will remain the most lucrative product in the market, followed by checkpoint regulators. In addition, sales of growth factors, and cytokines are poised to exhibit similar CAGRs through 2022. However, sales of chemokines are estimated to register the fastest expansion through 2022. Demand for enzymes & inhibitors will continue to be sluggish throughout the forecast period.

Although academic & research institutes are expected to remain the largest end-users of recombinant proteins in terms of revenues, sales in biopharmaceutical companies will register the highest CAGR compared to all the other end-user segments through 2022. Revenues from sales of recombinant proteins in academic & research institutes will account for over one-third market share during 2017 to 2022.

Recombinant proteins will continue to find the largest application in basic research activities. Revenues from recombinant proteins for basic research are expected to account for around US$ 270 Mn by 2022-end. Drug discovery & development, and toxicity screening are estimated to emerge as the fastest growing applications of recombinant proteins. Sales of recombinant proteins for application in forensic testing are estimated to register the lowest CAGR through 2022.

Competition Tracking

Leading players in the global recombinant protein market include Abcam plc, A.M.S. Biotechnology (Europe) Limited, Bio-Rad Laboratories, Inc., BPS Bioscience Inc., PerkinElmer, Inc., Crown Bioscience, Inc., GenScript Corporation, Merck Millipore Limited, Sigma Aldrich, and Thermo Fisher Scientific, Inc.

NoteThe insights mentioned here are of the respective analysts, and do not reflect the position of Fact.MR

Recombinant proteins play an imperative role in treating various diseases, such as hemophilia. Majority of the recombinant proteins used are human proteins, in order to compensate the functional proteins in vivo defects by increasing the protein function in a body. This Fact.MR report analyzes the expansion of global recombinant protein market till date, and provides key insights on the growth of the market during the forecast period, 2017-2022.

Scope

The scope of Fact.MR’s report is to analyze the global recombinant protein market for the forecast period 2017-2022 and provide readers an unbiased and accurate analysis. Medical device manufacturers, research institutes, and raw material suppliers in the global recombinant protein market can benefit from the analysis offered in this report. This report offers a comprehensive analysis, which can be of interest to leading trade magazines and medical journals pertaining to recombinant protein.

Summary

The report commences with a brief information of the global recombinant protein market. This executive summary sets the tone for the rest of the report, providing users the scope of the report. The executive summary includes important facts and statistics on the global recombinant protein market.

Overview

The next section offers an overview of the global recombinant protein market. This comprises an introduction to the market, along with a standard definition of the product – recombinant protein. In this section, market value and year-over-year growth is offered to the readers. Year-over-year growth provides readers with a broader view of growth patterns over the forecast period.

The report’s succeeding section focuses on drivers, restraints and key trends from macroeconomic, demand, and supply perspectives. Impact analysis of weighted average model-based growth drivers is contained in the report for better provision of decision-making insights to clients.

In order to offer readers with up-to-date information about the latest advancements in the global recombinant protein market, the report provides updates about market opportunities, which can benefit leading manufacturers of recombinant protein. With continuous evolution of the healthcare sector, keeping a record of latest developments and trends is fundamental for recombinant protein manufacturers to formulate key business strategies. Detailed insights about raw material sourcing, supply chain, regulatory approvals, pricing analysis, list of distributors, and cost structure are provided in this section.

The report by Fact.MR provides segment-wise analysis and forecast for covering the wide scope of global recombinant protein market. The global recombinant protein market has been segmented on the basis of application, product type, end-user, and region. In this segmentation analysis, a detailed country-wise forecast across all key market parameters is also included.

The report’s last section comprises of the global recombinant protein market competitive landscape, to provide readers with the dashboard view of company analysis and market players. This competitive intelligence is based on the providers’ categories across value chain, and their presence in the global recombinant protein market.

Research Methodology

Fact.MR is committed to offer unbiased and independent market research solutions to its clients. Each market report of Fact.MR is compiled after months of exhaustive research. We bank on a mix of tried-and-tested and innovative research methodologies to offer the most comprehensive and accurate information. Our main sources of research include,

  • Primary research
  • Secondary research
  • Trade research
  • Focused interviews
  • Social media analysis

1. Global Recombinant Proteins Market - Executive Summary

2. Global Recombinant Proteins Market Overview
2.1. Introduction
       2.1.1. Global Recombinant Proteins Market Taxonomy
       2.1.2. Global Recombinant Proteins Market Definition
2.2. Global Recombinant Proteins Market Size (US$ Mn) and Forecast, 2012-2022
       2.2.1. Global Recombinant Proteins Market Y-o-Y Growth
2.3. Global Recombinant Proteins Market Dynamics
2.4. Regulations
2.5. Supply Chain
2.6. Cost Structure
2.7. Average Pricing Analysis 
2.8. List of Distributors
2.9. Key Participants Market Presence (Intensity Map) By Region

3. Global Recombinant Proteins Market Analysis and Forecast By Product Type 
3.1. Global Recombinant Proteins Market Size and Forecast By Product Type, 2012-2022
       3.1.1. Immune Checkpoint Regulators Recombinant Proteins Market Size and Forecast, 2012-2022
                3.1.1.1. Revenue (US$ Mn) Comparison, By Region
                3.1.1.2. Market Share Comparison, By Region
                3.1.1.3. Y-o-Y growth Comparison, By Region
       3.1.2. Chemokines Recombinant Proteins Market Size and Forecast, 2012-2022
                3.1.2.1. Revenue (US$ Mn) Comparison, By Region
                3.1.2.2. Market Share Comparison, By Region
                3.1.2.3. Y-o-Y growth Comparison, By Region
       3.1.3. Growth Factors Recombinant Proteins Market Size and Forecast, 2012-2022
                3.1.3.1. Revenue (US$ Mn) Comparison, By Region
                3.1.3.2. Market Share Comparison, By Region
                3.1.3.3. Y-o-Y growth Comparison, By Region
       3.1.4. Cytokines Recombinant Proteins Market Size and Forecast, 2012-2022
                3.1.4.1. Revenue (US$ Mn) Comparison, By Region
                3.1.4.2. Market Share Comparison, By Region
                3.1.4.3. Y-o-Y growth Comparison, By Region
       3.1.5. Colony Stimulating Factors Recombinant Proteins Market Size and Forecast, 2012-2022
                3.1.5.1. Revenue (US$ Mn) Comparison, By Region
                3.1.5.2. Market Share Comparison, By Region
                3.1.5.3. Y-o-Y growth Comparison, By Region
       3.1.6. Hormones Recombinant Proteins Market Size and Forecast, 2012-2022
                3.1.6.1. Revenue (US$ Mn) Comparison, By Region
                3.1.6.2. Market Share Comparison, By Region
                3.1.6.3. Y-o-Y growth Comparison, By Region
       3.1.7. Enzymes & Inhibitors Recombinant Proteins Market Size and Forecast, 2012-2022
                3.1.7.1. Revenue (US$ Mn) Comparison, By Region
                3.1.7.2. Market Share Comparison, By Region
                3.1.7.3. Y-o-Y growth Comparison, By Region
       3.1.8. Other  Recombinant Proteins Market Size and Forecast, 2012-2022
                3.1.8.1. Revenue (US$ Mn) Comparison, By Region
                3.1.8.2. Market Share Comparison, By Region
                3.1.8.3. Y-o-Y growth Comparison, By Region

4. Global Recombinant Proteins Market Analysis and Forecast By End User 
4.1. Global Recombinant Proteins Market Size and Forecast By End User, 2012-2022
       4.1.1. Biopharmaceutical Companies Recombinant Proteins Market Size and Forecast, 2012-2022
                4.1.1.1. Revenue (US$ Mn) Comparison, By Region
                4.1.1.2. Market Share Comparison, By Region
                4.1.1.3. Y-o-Y growth Comparison, By Region
       4.1.2. Contract Research Organizations (CROs) Recombinant Proteins Market Size and Forecast, 2012-2022
                4.1.2.1. Revenue (US$ Mn) Comparison, By Region
                4.1.2.2. Market Share Comparison, By Region
                4.1.2.3. Y-o-Y growth Comparison, By Region
       4.1.3. Academic & Research Institutes Recombinant Proteins Market Size and Forecast, 2012-2022
                4.1.3.1. Revenue (US$ Mn) Comparison, By Region
                4.1.3.2. Market Share Comparison, By Region
                4.1.3.3. Y-o-Y growth Comparison, By Region
       4.1.4. Forensic Science Laboratories Recombinant Proteins Market Size and Forecast, 2012-2022
                4.1.4.1. Revenue (US$ Mn) Comparison, By Region
                4.1.4.2. Market Share Comparison, By Region
                4.1.4.3. Y-o-Y growth Comparison, By Region
       4.1.5. Food & Beverage Companies Recombinant Proteins Market Size and Forecast, 2012-2022
                4.1.5.1. Revenue (US$ Mn) Comparison, By Region
                4.1.5.2. Market Share Comparison, By Region
                4.1.5.3. Y-o-Y growth Comparison, By Region
       4.1.6. Diagnostic Centers Recombinant Proteins Market Size and Forecast, 2012-2022
                4.1.6.1. Revenue (US$ Mn) Comparison, By Region
                4.1.6.2. Market Share Comparison, By Region
                4.1.6.3. Y-o-Y growth Comparison, By Region
       4.1.7. Others Recombinant Proteins Market Size and Forecast, 2012-2022
                4.1.7.1. Revenue (US$ Mn) Comparison, By Region
                4.1.7.2. Market Share Comparison, By Region
                4.1.7.3. Y-o-Y growth Comparison, By Region

5. Global Recombinant Proteins Market Analysis and Forecast By Application 
5.1. Global Recombinant Proteins Market Size and Forecast By Application, 2012-2022
       5.1.1. Drug Discovery & Development Recombinant Proteins Market Size and Forecast, 2012-2022
                5.1.1.1. Revenue (US$ Mn) Comparison, By Region
                5.1.1.2. Market Share Comparison, By Region
                5.1.1.3. Y-o-Y growth Comparison, By Region
       5.1.2. Basic Research Recombinant Proteins Market Size and Forecast, 2012-2022
                5.1.2.1. Revenue (US$ Mn) Comparison, By Region
                5.1.2.2. Market Share Comparison, By Region
                5.1.2.3. Y-o-Y growth Comparison, By Region
       5.1.3. Toxicity Screening Recombinant Proteins Market Size and Forecast, 2012-2022
                5.1.3.1. Revenue (US$ Mn) Comparison, By Region
                5.1.3.2. Market Share Comparison, By Region
                5.1.3.3. Y-o-Y growth Comparison, By Region
       5.1.4. Biopharmaceutical Production Recombinant Proteins Market Size and Forecast, 2012-2022
                5.1.4.1. Revenue (US$ Mn) Comparison, By Region
                5.1.4.2. Market Share Comparison, By Region
                5.1.4.3. Y-o-Y growth Comparison, By Region
       5.1.5. Drug Screening Recombinant Proteins Market Size and Forecast, 2012-2022
                5.1.5.1. Revenue (US$ Mn) Comparison, By Region
                5.1.5.2. Market Share Comparison, By Region
                5.1.5.3. Y-o-Y growth Comparison, By Region
       5.1.6. Tissue Engineering Recombinant Proteins Market Size and Forecast, 2012-2022
                5.1.6.1. Revenue (US$ Mn) Comparison, By Region
                5.1.6.2. Market Share Comparison, By Region
                 5.1.6.3. Y-o-Y growth Comparison, By Region
       5.1.7. Forensic Testing Recombinant Proteins Market Size and Forecast, 2012-2022
                5.1.7.1. Revenue (US$ Mn) Comparison, By Region
                5.1.7.2. Market Share Comparison, By Region
                5.1.7.3. Y-o-Y growth Comparison, By Region

6. Global Recombinant Proteins Market Analysis and Forecast By Region
6.1. Global Recombinant Proteins Market Size and Forecast, 2012-2022
       6.1.1. North America Recombinant Proteins Market Size and Forecast, 2012-2022
                6.1.1.1. Revenue (US$ Mn) Comparison, By Product Type 
                6.1.1.2. Revenue (US$ Mn) Comparison, By End User 
                6.1.1.3. Revenue (US$ Mn) Comparison, By Application 
       6.1.2. Latin America Recombinant Proteins Market Size and Forecast, 2012-2022
                6.1.2.1. Revenue (US$ Mn) Comparison, By Product Type 
                6.1.2.2. Revenue (US$ Mn) Comparison, By End User 
                 6.1.2.3. Revenue (US$ Mn) Comparison, By Application 
       6.1.3. Europe Recombinant Proteins Market Size and Forecast, 2012-2022
                6.1.3.1. Revenue (US$ Mn) Comparison, By Product Type 
                6.1.3.2. Revenue (US$ Mn) Comparison, By End User 
                6.1.3.3. Revenue (US$ Mn) Comparison, By Application 
       6.1.4. Japan Recombinant Proteins Market Size and Forecast, 2012-2022
                6.1.4.1. Revenue (US$ Mn) Comparison, By Product Type 
                6.1.4.2. Revenue (US$ Mn) Comparison, By End User 
                6.1.4.3. Revenue (US$ Mn) Comparison, By Application 
       6.1.5. APEJ Recombinant Proteins Market Size and Forecast, 2012-2022
                6.1.5.1. Revenue (US$ Mn) Comparison, By Product Type 
                6.1.5.2. Revenue (US$ Mn) Comparison, By End User 
                6.1.5.3. Revenue (US$ Mn) Comparison, By Application 
       6.1.6. MEA Recombinant Proteins Market Size and Forecast, 2012-2022
                6.1.6.1. Revenue (US$ Mn) Comparison, By Product Type 
                6.1.6.2. Revenue (US$ Mn) Comparison, By End User 
                6.1.6.3. Revenue (US$ Mn) Comparison, By Application 

7. North America Recombinant Proteins Market Analysis and Forecast, By Country, 2012-2022
7.1. US Recombinant Proteins Market Size and Forecast, 2012-2022
       7.1.1. Revenue (US$ Mn) Comparison, By Product Type 
       7.1.2. Revenue (US$ Mn) Comparison, By End User 
       7.1.3. Revenue (US$ Mn) Comparison, By Application 
7.2. Canada Recombinant Proteins Market Size and Forecast, 2012-2022
       7.2.1. Revenue (US$ Mn) Comparison, By Product Type 
       7.2.2. Revenue (US$ Mn) Comparison, By End User 
       7.2.3. Revenue (US$ Mn) Comparison, By Application 

8. Latin America Recombinant Proteins Market Analysis and Forecast, By Country, 2012-2022
8.1. Brazil Recombinant Proteins Market Size and Forecast, 2012-2022
       8.1.1. Revenue (US$ Mn) Comparison, By Product Type 
       8.1.2. Revenue (US$ Mn) Comparison, By End User 
       8.1.3. Revenue (US$ Mn) Comparison, By Application 
8.2. Mexico Recombinant Proteins Market Size and Forecast, 2012-2022
       8.2.1. Revenue (US$ Mn) Comparison, By Product Type 
       8.2.2. Revenue (US$ Mn) Comparison, By End User 
       8.2.3. Revenue (US$ Mn) Comparison, By Application 
8.3. Argentina Recombinant Proteins Market Size and Forecast, 2012-2022
       8.3.1. Revenue (US$ Mn) Comparison, By Product Type 
       8.3.2. Revenue (US$ Mn) Comparison, By End User 
       8.3.3. Revenue (US$ Mn) Comparison, By Application 

9. Europe Recombinant Proteins Market Analysis and Forecast, By Country, 2012-2022
9.1. Germany Recombinant Proteins Market Size and Forecast, 2012-2022
       9.1.1. Revenue (US$ Mn) Comparison, By Product Type 
       9.1.2. Revenue (US$ Mn) Comparison, By End User 
       9.1.3. Revenue (US$ Mn) Comparison, By Application 
9.2. UK Recombinant Proteins Market Size and Forecast, 2012-2022
       9.2.1. Revenue (US$ Mn) Comparison, By Product Type 
       9.2.2. Revenue (US$ Mn) Comparison, By End User 
       9.2.3. Revenue (US$ Mn) Comparison, By Application 
9.3. France Recombinant Proteins Market Size and Forecast, 2012-2022
       9.3.1. Revenue (US$ Mn) Comparison, By Product Type 
       9.3.2. Revenue (US$ Mn) Comparison, By End User 
       9.3.3. Revenue (US$ Mn) Comparison, By Application 
9.4. Spain Recombinant Proteins Market Size and Forecast, 2012-2022
       9.4.1. Revenue (US$ Mn) Comparison, By Product Type 
       9.4.2. Revenue (US$ Mn) Comparison, By End User 
       9.4.3. Revenue (US$ Mn) Comparison, By Application 
9.5. Italy Recombinant Proteins Market Size and Forecast, 2012-2022
       9.5.1. Revenue (US$ Mn) Comparison, By Product Type 
       9.5.2. Revenue (US$ Mn) Comparison, By End User 
       9.5.3. Revenue (US$ Mn) Comparison, By Application 
9.6. Nordic Recombinant Proteins Market Size and Forecast, 2012-2022
       9.6.1. Revenue (US$ Mn) Comparison, By Product Type 
       9.6.2. Revenue (US$ Mn) Comparison, By End User 
       9.6.3. Revenue (US$ Mn) Comparison, By Application 

10. Japan Recombinant Proteins Market Analysis and Forecast, By Country, 2012-2022
10.1. Japan  Recombinant Proteins Market Size and Forecast, 2012-2022
       10.1.1. Revenue (US$ Mn) Comparison, By Product Type 
       10.1.2. Revenue (US$ Mn) Comparison, By End User 
       10.1.3. Revenue (US$ Mn) Comparison, By Application 

11. APEJ Recombinant Proteins Market Analysis and Forecast, By Country, 2012-2022
11.1. China Recombinant Proteins Market Size and Forecast, 2012-2022
       11.1.1. Revenue (US$ Mn) Comparison, By Product Type 
       11.1.2. Revenue (US$ Mn) Comparison, By End User 
       11.1.3. Revenue (US$ Mn) Comparison, By Application 
11.2. India Recombinant Proteins Market Size and Forecast, 2012-2022
       11.2.1. Revenue (US$ Mn) Comparison, By Product Type 
       11.2.2. Revenue (US$ Mn) Comparison, By End User 
       11.2.3. Revenue (US$ Mn) Comparison, By Application 
11.3. Malaysia Recombinant Proteins Market Size and Forecast, 2012-2022
       11.3.1. Revenue (US$ Mn) Comparison, By Product Type 
       11.3.2. Revenue (US$ Mn) Comparison, By End User 
       11.3.3. Revenue (US$ Mn) Comparison, By Application 
11.4. Thailand Recombinant Proteins Market Size and Forecast, 2012-2022
       11.4.1. Revenue (US$ Mn) Comparison, By Product Type 
       11.4.2. Revenue (US$ Mn) Comparison, By End User 
       11.4.3. Revenue (US$ Mn) Comparison, By Application 
11.5. Singapore Recombinant Proteins Market Size and Forecast, 2012-2022
       11.5.1. Revenue (US$ Mn) Comparison, By Product Type 
       11.5.2. Revenue (US$ Mn) Comparison, By End User 
       11.5.3. Revenue (US$ Mn) Comparison, By Application 
11.6. Australia Recombinant Proteins Market Size and Forecast, 2012-2022
       11.6.1. Revenue (US$ Mn) Comparison, By Product Type 
       11.6.2. Revenue (US$ Mn) Comparison, By End User 
       11.6.3. Revenue (US$ Mn) Comparison, By Application 

12. MEA Recombinant Proteins Market Analysis and Forecast, By Country, 2012-2022
12.1. GCC Countries Recombinant Proteins Market Size and Forecast, 2012-2022
       12.1.1. Revenue (US$ Mn) Comparison, By Product Type 
       12.1.2. Revenue (US$ Mn) Comparison, By End User 
       12.1.3. Revenue (US$ Mn) Comparison, By Application 
12.2. South Africa Recombinant Proteins Market Size and Forecast, 2012-2022
       12.2.1. Revenue (US$ Mn) Comparison, By Product Type 
       12.2.2. Revenue (US$ Mn) Comparison, By End User 
       12.2.3. Revenue (US$ Mn) Comparison, By Application 
12.3. Nigeria Recombinant Proteins Market Size and Forecast, 2012-2022
       12.3.1. Revenue (US$ Mn) Comparison, By Product Type 
       12.3.2. Revenue (US$ Mn) Comparison, By End User 
       12.3.3. Revenue (US$ Mn) Comparison, By Application 
12.4. Israel Recombinant Proteins Market Size and Forecast, 2012-2022
       12.4.1. Revenue (US$ Mn) Comparison, By Product Type 
       12.4.2. Revenue (US$ Mn) Comparison, By End User 
       12.4.3. Revenue (US$ Mn) Comparison, By Application 

13. Global Recombinant Proteins Market Competition Landscape and Company Profile
13.1. Company Share Analysis By Region
13.2. Abcam plc
       13.2.1. Company Overview
       13.2.2. Recombinant Proteins Market Product Type list
       13.2.3. Recombinant Proteins Market Product Type Sales Data and Key Financials
       13.2.4. Key Developments
       13.2.5. SWOT Analysis
13.3. A.M.S. Biotechnology (Europe) Limited
       13.3.1. Company Overview
       13.3.2. Recombinant Proteins Market Product Type list
       13.3.3. Recombinant Proteins Market Product Type Sales Data and Key Financials
       13.3.4. Key Developments
       13.3.5. SWOT Analysis
13.4. Bio-Rad Laboratories, Inc
       13.4.1. Company Overview
       13.4.2. Recombinant Proteins Market Product Type list
       13.4.3. Recombinant Proteins Market Product Type Sales Data and Key Financials
       13.4.4. Key Developments
       13.4.5. SWOT Analysis
13.5. BPS Bioscience Inc
       13.5.1. Company Overview
       13.5.2. Recombinant Proteins Market Product Type list
       13.5.3. Recombinant Proteins Market Product Type Sales Data and Key Financials
       13.5.4. Key Developments
       13.5.5. SWOT Analysis
13.6. PerkinElmer, Inc.
       13.6.1. Company Overview
       13.6.2. Recombinant Proteins Market Product Type list
       13.6.3. Recombinant Proteins Market Product Type Sales Data and Key Financials
       13.6.4. Key Developments
       13.6.5. SWOT Analysis
13.7. Crown Bioscience, Inc.
       13.7.1. Company Overview
       13.7.2. Recombinant Proteins Market Product Type list
       13.7.3. Recombinant Proteins Market Product Type Sales Data and Key Financials
       13.7.4. Key Developments
       13.7.5. SWOT Analysis
13.8. GenScript Corporation
       13.8.1. Company Overview
       13.8.2. Recombinant Proteins Market Product Type list
       13.8.3. Recombinant Proteins Market Product Type Sales Data and Key Financials
       13.8.4. Key Developments
       13.8.5. SWOT Analysis
13.9. Merck Millipore Limited
       13.9.1. Company Overview
       13.9.2. Recombinant Proteins Market Product Type list
       13.9.3. Recombinant Proteins Market Product Type Sales Data and Key Financials
       13.9.4. Key Developments
       13.9.5. SWOT Analysis
13.10. Sigma Aldrich
       13.10.1. Company Overview
       13.10.2. Recombinant Proteins Market Product Type list
       13.10.3. Recombinant Proteins Market Product Type Sales Data and Key Financials
       13.10.4. Key Developments
       13.10.5. SWOT Analysis
13.11. Thermo Fisher Scientific, Inc
       13.11.1. Company Overview
       13.11.2. Recombinant Proteins Market Product Type list
       13.11.3. Recombinant Proteins Market Product Type Sales Data and Key Financials
       13.11.4. Key Developments
       13.11.5. SWOT Analysis

14. Research Methodology

15. Secondary and Primary Sources

16. Assumptions and Acronyms

17. Disclaimer

Fact.MR offers custom research services that help clients to get specific research solutions

We are committed towards customer satisfaction and quality service.


Our Clients

Malaysian Cocoa Board
Dunlop International Europe Ltd
Roland Berger
Superior Essex
Commscope
Deloitte

Fact.MR in Media

Recombinant Protein Market Forecast, Trend Analysis & Competition Tracking: Global Market insights 2017 to 2022